Bank Julius Baer & Co’s Fate Therapeutics FATE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q3
Sell
-280
Closed -$1K 532
2023
Q2
$1K Hold
280
﹤0.01% 557
2023
Q1
$2K Hold
280
﹤0.01% 581
2022
Q4
$3K Sell
280
-9,106
-97% -$97.6K ﹤0.01% 566
2022
Q3
$210K Sell
9,386
-3,742
-29% -$83.7K ﹤0.01% 398
2022
Q2
$325K Sell
13,128
-6,022
-31% -$149K ﹤0.01% 370
2022
Q1
$742K Buy
19,150
+437
+2% +$16.9K ﹤0.01% 312
2021
Q4
$1.1M Buy
+18,713
New +$1.1M 0.01% 337